People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by health ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...

Vertex has enacted or continued several key launches in 2025. These include its new once-daily triple-combination therapy for ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...

Image from Modular Medical on LinkedIn]Modular Medical (Nasdaq:MODD) announced that it continues to progress toward CE mark ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.

The New York-based biotech is at the centre of a bidding war between Novo Nordisk and Pfizer, both vying for access to its pipeline of experimental treatments as competition intensifies in the booming ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Sprouts employs approximately 35,000 associates and operates more than 450 stores in 24 states nationwide. The Phoenix-based ...

Cigna will remove drug rebates from 2027, replacing them with upfront discounts that could change how Americans pay for ...

Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...